Silver diamine fluoride with sodium fluoride varnish versus silver diamine fluoride in arresting early childhood caries: a 6-months follow up of a randomized field trial.


Journal

BMC oral health
ISSN: 1472-6831
Titre abrégé: BMC Oral Health
Pays: England
ID NLM: 101088684

Informations de publication

Date de publication:
17 11 2023
Historique:
received: 19 06 2023
accepted: 30 10 2023
medline: 20 11 2023
pubmed: 18 11 2023
entrez: 18 11 2023
Statut: epublish

Résumé

Early childhood caries (ECC) is the most prevalent chronic health problem in young children, and it can be arrested using professionally applied fluoride such as Sodium fluoride (NaF) varnish and Silver Diamine Fluoride (SDF). This trial compared two interventions to arrest ECC lesions: 38% SDF combined with 5% NaF varnish versus 38% SDF and assessed whether the arrest rate was affected by baseline lesion severity measured by ICDAS. Children aged ≤ 4 years from 4 nurseries in a rural area in Alexandria, Egypt joined the study in March 2022. They were included if they had at least one active carious lesion with ICDAS codes ≥ 3. They were randomized to receive either 38% SDF with 5% NaF varnish or 38% SDF alone. In both groups, the agents were applied at baseline and after 6 months on the caries lesions. NaF was additionally applied on all teeth in the oral cavity, and it was also applied after three months. The primary outcome was lesion arrest status after six months. Parents' satisfaction with their children's appearance was the secondary outcome. Pearson Chi-Square test was used for bivariate comparison and multi-level multiple logistic regression was used to assess the effect of the intervention on caries arrest controlling for confounders. The interaction between the intervention and baseline lesion severity (categorized into moderate and severe lesions) was assessed and the p value was calculated. The study included 1606 lesions in 220 children, median (IQR) age = 48(9) months. The percentages of arrested lesions after the application of SDF + NaF and SDF only were 77.7% and 73.2% (p = 0.035). In multivariable analysis, SDF + NaF had significantly greater caries arrest effect than SDF alone (AOR = 2.12, p = 0.03) with significant difference (p = 0.03) between moderate (AOR = 4.10, p = 0.005) and advanced (AOR = 1.92, p = 0.08) lesions. Most parents were satisfied with their children's appearance with no significant difference between groups (SDF + NaF = 84.5%, SDF = 78.18%, p = 0.23). SDF + NaF had a higher arrest rate than SDF alone and this difference was significant in moderate but not advanced lesions. The findings have implications for the non-invasive management of ECC. This trial was registered in the clinicaltrials.gov registry (#NCT05642494).

Sections du résumé

BACKGROUND
Early childhood caries (ECC) is the most prevalent chronic health problem in young children, and it can be arrested using professionally applied fluoride such as Sodium fluoride (NaF) varnish and Silver Diamine Fluoride (SDF). This trial compared two interventions to arrest ECC lesions: 38% SDF combined with 5% NaF varnish versus 38% SDF and assessed whether the arrest rate was affected by baseline lesion severity measured by ICDAS.
METHODS
Children aged ≤ 4 years from 4 nurseries in a rural area in Alexandria, Egypt joined the study in March 2022. They were included if they had at least one active carious lesion with ICDAS codes ≥ 3. They were randomized to receive either 38% SDF with 5% NaF varnish or 38% SDF alone. In both groups, the agents were applied at baseline and after 6 months on the caries lesions. NaF was additionally applied on all teeth in the oral cavity, and it was also applied after three months. The primary outcome was lesion arrest status after six months. Parents' satisfaction with their children's appearance was the secondary outcome. Pearson Chi-Square test was used for bivariate comparison and multi-level multiple logistic regression was used to assess the effect of the intervention on caries arrest controlling for confounders. The interaction between the intervention and baseline lesion severity (categorized into moderate and severe lesions) was assessed and the p value was calculated.
RESULTS
The study included 1606 lesions in 220 children, median (IQR) age = 48(9) months. The percentages of arrested lesions after the application of SDF + NaF and SDF only were 77.7% and 73.2% (p = 0.035). In multivariable analysis, SDF + NaF had significantly greater caries arrest effect than SDF alone (AOR = 2.12, p = 0.03) with significant difference (p = 0.03) between moderate (AOR = 4.10, p = 0.005) and advanced (AOR = 1.92, p = 0.08) lesions. Most parents were satisfied with their children's appearance with no significant difference between groups (SDF + NaF = 84.5%, SDF = 78.18%, p = 0.23).
CONCLUSION
SDF + NaF had a higher arrest rate than SDF alone and this difference was significant in moderate but not advanced lesions. The findings have implications for the non-invasive management of ECC.
TRIAL REGISTRATION
This trial was registered in the clinicaltrials.gov registry (#NCT05642494).

Identifiants

pubmed: 37978488
doi: 10.1186/s12903-023-03597-5
pii: 10.1186/s12903-023-03597-5
pmc: PMC10656986
doi:

Substances chimiques

Sodium Fluoride 8ZYQ1474W7
silver diamine fluoride DDU19UEV1Y
Fluorides, Topical 0
Cariostatic Agents 0
Silver Compounds 0
Quaternary Ammonium Compounds 0
Sodium 9NEZ333N27

Banques de données

ClinicalTrials.gov
['NCT05642494']

Types de publication

Randomized Controlled Trial Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

875

Informations de copyright

© 2023. The Author(s).

Références

BMC Oral Health. 2019 Jul 12;19(1):145
pubmed: 31299955
Pediatr Dent. 2016 Oct;38(6):52-54
pubmed: 27931420
J Public Health Dent. 2018 Dec;78(1):63-68
pubmed: 28749529
J Dent. 2018 Mar;70:74-79
pubmed: 29289726
JAMA. 2013 Nov 27;310(20):2191-4
pubmed: 24141714
J Dent. 2013 Sep;41(9):809-17
pubmed: 23810851
Behav Res Methods. 2007 May;39(2):175-91
pubmed: 17695343
Dent J (Basel). 2016 Jun 08;4(2):
pubmed: 29563462
J Indian Soc Pedod Prev Dent. 2022 Oct-Dec;40(4):377-382
pubmed: 36861553
Pediatr Dent. 2000 Nov-Dec;22(6):513-6
pubmed: 11132514
JDR Clin Trans Res. 2016 Jul;1(2):143-152
pubmed: 28989974
Biochem Med (Zagreb). 2012;22(3):276-82
pubmed: 23092060
Pediatr Dent. 2016 Nov 15;38(7):466-471
pubmed: 28281949
J Dent. 2014 Apr;42(4):395-402
pubmed: 24373856
J Can Dent Assoc. 2020 Jun;86:k9
pubmed: 32543369
Community Dent Oral Epidemiol. 2007 Jun;35(3):170-8
pubmed: 17518963
BMC Med. 2010 Mar 24;8:18
pubmed: 20334633
Ann R Australas Coll Dent Surg. 2008 Jun;19:58-61
pubmed: 19728633
Oper Dent. 2007 May-Jun;32(3):225-35
pubmed: 17555173
J Dent. 2020 Aug;99:103375
pubmed: 32428523
BMC Oral Health. 2020 Jan 28;20(1):21
pubmed: 31992291
J Dent Anesth Pain Med. 2019 Dec;19(6):313-322
pubmed: 31942447
J Dent Res. 2018 Apr;97(4):395-401
pubmed: 29237131
J Dent Res. 2020 Apr;99(4):362-373
pubmed: 32122215
J Nat Sci Biol Med. 2013 Jan;4(1):29-38
pubmed: 23633832
Heliyon. 2020 Jul 17;6(7):e04287
pubmed: 32715116
Int J Dent Hyg. 2022 Feb;20(1):120-135
pubmed: 33825317
Acta Odontol Scand. 1964 Feb;22:121-35
pubmed: 14158464
Caries Res. 2017;51(5):527-541
pubmed: 28972954
BMC Oral Health. 2016 Feb 01;16:12
pubmed: 26831727
Am J Public Health. 2018 Aug;108(8):1066-1072
pubmed: 29927650
Int J Environ Res Public Health. 2022 Jul 24;19(15):
pubmed: 35897363

Auteurs

Enas B Abdellatif (EB)

Department of Pediatric Dentistry and Dental Public Health, Faculty of Dentistry, Alexandria University, Champolion St, Azarita, 21527, Alexandria, Egypt. enas.belal@alexu.edu.eg.

Mona K El Kashlan (MK)

Department of Pediatric Dentistry and Dental Public Health, Faculty of Dentistry, Alexandria University, Champolion St, Azarita, 21527, Alexandria, Egypt.

Maha El Tantawi (M)

Department of Pediatric Dentistry and Dental Public Health, Faculty of Dentistry, Alexandria University, Champolion St, Azarita, 21527, Alexandria, Egypt.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH